Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 21,788,519
- Share change
- +3,729,510
- Total reported value
- $6,659,692
- Price per share
- $0.31
- Number of holders
- 48
- Value change
- +$1,059,340
- Number of buys
- 14
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13D/G
13F
|
Company |
10%
|
6,127,662
|
$5,269,789 | $0 | 19 Mar 2025 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| GC Wealth Management RIA, LLC |
13F
|
Company |
7.9%
|
3,431,644
|
$2,466,323 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
3,039,322
|
$2,185,273 | — | 30 Sep 2025 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| Slate Path Capital LP |
13D/G
|
— |
1.4%
|
918,836
|
$790,199 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
800,768
|
$575,604 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
610,964
|
$439,100 | — | 30 Sep 2025 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$343,898 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1%
|
449,162
|
$322,813 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.75%
|
324,521
|
$233,005 | — | 30 Sep 2025 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$184,868 | — | 30 Sep 2025 | |
| Daniel R. Passeri |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
614,578
mixed-class rows
|
$169,515 | — | 21 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
227,064
|
$163,191 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.46%
|
199,158
|
$143,195 | — | 30 Sep 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.45%
|
196,556
|
$141,265 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
189,753
|
$136,375 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.38%
|
166,456
|
$119,632 | — | 30 Sep 2025 | |
| ANGELES WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
120,000
|
$86,244 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.23%
|
100,958
|
$72,559 | — | 30 Sep 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.2%
|
85,937
|
$63,466 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.2%
|
85,800
|
$61,664 | — | 30 Sep 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.18%
|
79,500
|
$57,136 | — | 30 Sep 2025 | |
| Sigma Planning Corp |
13F
|
Company |
0.12%
|
53,300
|
$38,307 | — | 30 Sep 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.11%
|
46,390
|
$33,340 | — | 30 Sep 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.09%
|
39,514
|
$28,399 | — | 30 Sep 2025 | |
| Texas Capital Bank Wealth Management Services Inc |
13F
|
Company |
0.08%
|
33,102
|
$23,790 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
27,512
|
$19,773 | — | 30 Sep 2025 | |
| Navalign, LLC |
13F
|
Company |
0.06%
|
25,000
|
$17,968 | — | 30 Sep 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.05%
|
20,000
|
$14,374 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
19,577
|
$14,070 | — | 30 Sep 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
20,000
|
$14,000 | — | 30 Sep 2025 | |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC |
13F
|
Company |
0.04%
|
18,987
|
$13,646 | — | 30 Sep 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
15,079
|
$11,000 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
14,741
|
$10,594 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
14,390
|
$10,342 | — | 30 Sep 2025 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.02%
|
10,000
|
$8,580 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
10,135
|
$7,284 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$4,333 | — | 30 Sep 2025 | |
| Gleason Group, Inc. |
13F
|
Company |
0.01%
|
6,000
|
$4,312 | — | 30 Sep 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
4,832
|
$3,000 | — | 30 Sep 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
3,000
|
$2,156 | — | 30 Sep 2025 | |
| Golden State Wealth Management, LLC |
13F
|
Company |
0%
|
2,000
|
$1,437 | — | 30 Sep 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
1,500
|
$1,078 | — | 30 Sep 2025 | |
| Physician Wealth Advisors, Inc. |
13F
|
Company |
0%
|
1,006
|
$724 | — | 30 Sep 2025 | |
| MATHER GROUP, LLC. |
13F
|
Company |
0%
|
1,000
|
$719 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
904
|
$650 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
680
|
$512 | — | 30 Sep 2025 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2025
As of 31 Dec 2025,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,788,519 shares.
The largest 10 holders included
Bleichroeder LP, GC Wealth Management RIA, LLC, VANGUARD GROUP INC, Lion Point Capital, LP, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, BlackRock, Inc., Texas Capital Bank Wealth Management Services Inc, and ANGELES WEALTH MANAGEMENT, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
52
Q4 2025 holders
48
Holder diff
-4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.